KBC Group
IDYA icon

KBC Group’s IDEAYA Biosciences IDYA Stock Holding History

KBC Group’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$134K Hold
3,608
– – ﹤0.01% 1236
2026
Q1 		$120K Hold
3,608
– – ﹤0.01% 1217
2025
Q4 		$125K Buy
3,608
+925
+34% +$29.5K ﹤0.01% 1143
2025
Q3 		$73K Hold
2,683
– – ﹤0.01% 1473
2025
Q2 		$56K Sell
2,683
-1,514
-36% -$29K ﹤0.01% 1555
2025
Q1 		$69K Hold
4,197
– – ﹤0.01% 1684
2024
Q4 		$108K Buy
4,197
+1,923
+85% +$54.4K ﹤0.01% 1501
2024
Q3 		$72K Buy
2,274
+513
+29% +$19.5K ﹤0.01% 1504
2024
Q2 		$62K Buy
1,761
+483
+38% +$19.1K ﹤0.01% 1485
2024
Q1 		$56K Buy
+1,278
New +$55K ﹤0.01% 1484

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

KBC Group's IDYA Position: Q2 2026 in Review

KBC Group held its IDEAYA Biosciences (IDYA) position steady in Q2 2026 at 3,608 shares worth $134K. The position accounts for ﹤0.01% of the portfolio, ranked #1236.

KBC Group first reported a position in IDYA in Q1 2024 and has held it in 10 quarters since. 285 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • KBC Group held 3,608 shares of IDEAYA Biosciences worth $134K as of Q2 2026.
  • KBC Group left its IDEAYA Biosciences share count unchanged in Q2 2026.
  • IDEAYA Biosciences made up ﹤0.01% of KBC Group's portfolio in Q2 2026, its #1236 holding.
  • KBC Group first reported a position in IDEAYA Biosciences in Q1 2024 and has held it in 10 quarters since.
  • 285 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on KBC Group's 13F filing for Q2 2026, filed 5 Aug 2026.